Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labomar develops and manufactures commercial-stage food supplements/nutraceuticals/devices/cosmetics. Products include patented formulations for iron supplementation ("IRONEC"), joint pain/inflammation ("VERBAXIB"), glucose control ("GLUCOCONTROL"), GERD management ("VEGAGERD", "GASTROSOMA REFLUX"), oropharyngeal mucositis gel ("MUCOBARRIER"), vaginal dryness gel ("RESVAGIL") among others. Clinical results are referenced in marketing materials for some products but detailed clinical trial data are not publicly available; most products are supported by scientific studies or literature as required for CE-marked medical devices or novel supplement claims.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labomar.